Author:
Saiman Lisa,Siegel Jane D.,LiPuma John J.,Brown Rebekah F.,Bryson Elizabeth A.,Chambers Mary Jo,Downer Veronica S.,Fliege Jill,Hazle Leslie A.,Jain Manu,Marshall Bruce C.,O’Malley Catherine,Pattee Suzanne R.,Potter-Bynoe Gail,Reid Siobhan,Robinson Karen A.,Sabadosa Kathryn A.,Schmidt H. Joel,Tullis Elizabeth,Webber Jennifer,Weber David J.
Abstract
The 2013 Infection Prevention and Control (IP&C) Guideline for Cystic Fibrosis (CF) was commissioned by the CF Foundation as an update of the 2003 Infection Control Guideline for CF. During the past decade, new knowledge and new challenges provided the following rationale to develop updated IP&C strategies for this unique population:1.The need to integrate relevant recommendations from evidence-based guidelines published since 2003 into IP&C practices for CF. These included guidelines from the Centers for Disease Control and Prevention (CDC)/Healthcare Infection Control Practices Advisory Committee (HICPAC), the World Health Organization (WHO), and key professional societies, including the Infectious Diseases Society of America (IDSA) and the Society for Healthcare Epidemiology of America (SHEA). During the past decade, new evidence has led to a renewed emphasis on source containment of potential pathogens and the role played by the contaminated healthcare environment in the transmission of infectious agents. Furthermore, an increased understanding of the importance of the application of implementation science, monitoring adherence, and feedback principles has been shown to increase the effectiveness of IP&C guideline recommendations.2.Experience with emerging pathogens in the non-CF population has expanded our understanding of droplet transmission of respiratory pathogens and can inform IP&C strategies for CF. These pathogens include severe acute respiratory syndrome coronavirus and the 2009 influenza A H1N1. Lessons learned about preventing transmission of methicillin-resistantStaphylococcus aureus(MRSA) and multidrug-resistant gram-negative pathogens in non-CF patient populations also can inform IP&C strategies for CF.
Publisher
Cambridge University Press (CUP)
Subject
Infectious Diseases,Microbiology (medical),Epidemiology
Reference500 articles.
1. Internet technology use by adults for socialization: impact of CF Foundation infection control guidelines;Ferrin;Pediatr Pulmonol,2010
2. Cystic Fibrosis Foundation. Cystic Fibrosis in the Workplace. http://www.cff.org/UploadedFiles/LivingWithCF/InWorkplace/CFInTheWorkplace.pdf. Published 2003. Accessed January 13, 2014.
3. Executive Summary: 2013 IDSA Clinical Practice Guideline for Vaccination of the Immunocompromised Host
4. Recent developments for Pseudomonas vaccines
5. Centers for Disease Control and Prevention. Building Air Quality: A Guide for Building Owners and Facility Managers. http://www.cdc.gov/niosh/docs/91-114/. Published 1991. Accessed January 13, 2014.
Cited by
324 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献